IGF1R and ovarian carcinoma: In addition, IGF1R expression was also increased in ovarian cancer tissue (Fig. 2Ec), with no significant difference identified between BRCA1 promoter methylation and expression (Fig. 2Ea and b); however, the increase was not significant when compared with that observed in ovarian cancer with BRCA1 deficiency.